Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 176 entries
Sorted by: Best Match Show Resources per page
Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case.

Oncology letters

Fornaro R, Caratto E, Caratto M, Salerno A, Sarocchi F, Minetti G, Frascio M, Murialdo R, Taviani M.
PMID: 26722296
Oncol Lett. 2015 Nov;10(5):3103-3106. doi: 10.3892/ol.2015.3684. Epub 2015 Sep 08.

Extra-abdominal fibromatosis is a rare, benign disease that is characterized by a local but not metastatic invasivity. In particular, desmoid tumors of the chest wall represent only 10-20% of all deep fibromatoses. The disease occurs more often in females...

Cite
Fornaro R, Caratto E, Caratto M, et al. Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case. Oncol Lett. 2015;10(5):3103-3106doi: 10.3892/ol.2015.3684.
Fornaro, R., Caratto, E., Caratto, M., Salerno, A., Sarocchi, F., Minetti, G., Frascio, M., Murialdo, R., & Taviani, M. (2015). Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case. Oncology letters, 10(5), 3103-3106. https://doi.org/10.3892/ol.2015.3684
Fornaro, Rosario, et al. "Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case." Oncology letters vol. 10,5 (2015): 3103-3106. doi: https://doi.org/10.3892/ol.2015.3684
Fornaro R, Caratto E, Caratto M, Salerno A, Sarocchi F, Minetti G, Frascio M, Murialdo R, Taviani M. Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case. Oncol Lett. 2015 Nov;10(5):3103-3106. doi: 10.3892/ol.2015.3684. Epub 2015 Sep 08. PMID: 26722296; PMCID: PMC4665811.
Copy Download .nbib Format: NLM
Surgical implantation of the CardioWest Total Artificial Heart.

Annals of cardiothoracic surgery

Tarzia V, Buratto E, Gallo M, Bortolussi G, Bejko J, Dal Lin C, Torregrossa G, Bianco R, Bottio T, Gerosa G.
PMID: 25512906
Ann Cardiothorac Surg. 2014 Nov;3(6):624-5. doi: 10.3978/j.issn.2225-319X.2014.08.16.

No abstract available.

Cite
Tarzia V, Buratto E, Gallo M, et al. Surgical implantation of the CardioWest Total Artificial Heart. Ann Cardiothorac Surg. 2014;3(6):624-5doi: 10.3978/j.issn.2225-319X.2014.08.16.
Tarzia, V., Buratto, E., Gallo, M., Bortolussi, G., Bejko, J., Dal Lin, C., Torregrossa, G., Bianco, R., Bottio, T., & Gerosa, G. (2014). Surgical implantation of the CardioWest Total Artificial Heart. Annals of cardiothoracic surgery, 3(6), 624-5. https://doi.org/10.3978/j.issn.2225-319X.2014.08.16
Tarzia, Vincenzo, et al. "Surgical implantation of the CardioWest Total Artificial Heart." Annals of cardiothoracic surgery vol. 3,6 (2014): 624-5. doi: https://doi.org/10.3978/j.issn.2225-319X.2014.08.16
Tarzia V, Buratto E, Gallo M, Bortolussi G, Bejko J, Dal Lin C, Torregrossa G, Bianco R, Bottio T, Gerosa G. Surgical implantation of the CardioWest Total Artificial Heart. Ann Cardiothorac Surg. 2014 Nov;3(6):624-5. doi: 10.3978/j.issn.2225-319X.2014.08.16. PMID: 25512906; PMCID: PMC4250547.
Copy Download .nbib Format: NLM
Mixtures of relativistic gases in gravitational fields: Combined Chapman-Enskog and Grad method and the Onsager relations.

Physical review. E, Statistical, nonlinear, and soft matter physics

Moratto V, Kremer GM.
PMID: 26066151
Phys Rev E Stat Nonlin Soft Matter Phys. 2015 May;91(5):052139. doi: 10.1103/PhysRevE.91.052139. Epub 2015 May 26.

In this work we study an r-species mixture of gases within the relativistic kinetic theory point of view. We use the relativistic covariant Boltzmann equation and incorporate the Schwarzschild metric. The method of solution of the Boltzmann equation is...

Cite
Moratto V, Kremer GM. Mixtures of relativistic gases in gravitational fields: Combined Chapman-Enskog and Grad method and the Onsager relations. Phys Rev E Stat Nonlin Soft Matter Phys. 2015;91(5):052139doi: 10.1103/PhysRevE.91.052139.
Moratto, V., & Kremer, G. M. (2015). Mixtures of relativistic gases in gravitational fields: Combined Chapman-Enskog and Grad method and the Onsager relations. Physical review. E, Statistical, nonlinear, and soft matter physics, 91(5), 052139. https://doi.org/10.1103/PhysRevE.91.052139
Moratto, Valdemar, and Kremer, Gilberto M. "Mixtures of relativistic gases in gravitational fields: Combined Chapman-Enskog and Grad method and the Onsager relations." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 91,5 (2015): 052139. doi: https://doi.org/10.1103/PhysRevE.91.052139
Moratto V, Kremer GM. Mixtures of relativistic gases in gravitational fields: Combined Chapman-Enskog and Grad method and the Onsager relations. Phys Rev E Stat Nonlin Soft Matter Phys. 2015 May;91(5):052139. doi: 10.1103/PhysRevE.91.052139. Epub 2015 May 26. PMID: 26066151.
Copy Download .nbib Format: NLM
The use of cation exchange matrix separation coupled with ICP-MS to directly determine platinum group element (PGE) and other trace element emissions from passenger cars equipped with diesel particulate filters (DPF).

Analytical and bioanalytical chemistry

Cairns WR, De Boni A, Cozzi G, Asti M, Borla EM, Parussa F, Moretto E, Cescon P, Boutron C, Gabrieli J, Barbante C.
PMID: 21210274
Anal Bioanal Chem. 2011 Mar;399(8):2731-40. doi: 10.1007/s00216-010-4596-5. Epub 2011 Jan 06.

Inductively coupled plasma-mass spectrometry coupled with cation exchange matrix separation has been optimised for the direct determination of platinum group element (PGE) and trace element emissions from a diesel engine car. After matrix separation method detection limits of 1.6...

Cite
Cairns WR, De Boni A, Cozzi G, et al. The use of cation exchange matrix separation coupled with ICP-MS to directly determine platinum group element (PGE) and other trace element emissions from passenger cars equipped with diesel particulate filters (DPF). Anal Bioanal Chem. 2011;399(8):2731-40doi: 10.1007/s00216-010-4596-5.
Cairns, W. R., De Boni, A., Cozzi, G., Asti, M., Borla, E. M., Parussa, F., Moretto, E., Cescon, P., Boutron, C., Gabrieli, J., & Barbante, C. (2011). The use of cation exchange matrix separation coupled with ICP-MS to directly determine platinum group element (PGE) and other trace element emissions from passenger cars equipped with diesel particulate filters (DPF). Analytical and bioanalytical chemistry, 399(8), 2731-40. https://doi.org/10.1007/s00216-010-4596-5
Cairns, Warren R L, et al. "The use of cation exchange matrix separation coupled with ICP-MS to directly determine platinum group element (PGE) and other trace element emissions from passenger cars equipped with diesel particulate filters (DPF)." Analytical and bioanalytical chemistry vol. 399,8 (2011): 2731-40. doi: https://doi.org/10.1007/s00216-010-4596-5
Cairns WR, De Boni A, Cozzi G, Asti M, Borla EM, Parussa F, Moretto E, Cescon P, Boutron C, Gabrieli J, Barbante C. The use of cation exchange matrix separation coupled with ICP-MS to directly determine platinum group element (PGE) and other trace element emissions from passenger cars equipped with diesel particulate filters (DPF). Anal Bioanal Chem. 2011 Mar;399(8):2731-40. doi: 10.1007/s00216-010-4596-5. Epub 2011 Jan 06. PMID: 21210274.
Copy Download .nbib Format: NLM
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC).

Cancer management and research

Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S.
PMID: 24399885
Cancer Manag Res. 2013 Nov 19;5:377-85. doi: 10.2147/CMAR.S47986.

Management of metastatic colorectal cancer requires a multimodal approach and must be performed by an experienced, multidisciplinary expert team. The optimal choice of the individual treatment modality, according to disease localization and extent, tumor biology, and patient clinical characteristics,...

Cite
Rossi L, Vakiarou F, Zoratto F, et al. Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC). Cancer Manag Res. 2013;5:377-85doi: 10.2147/CMAR.S47986.
Rossi, L., Vakiarou, F., Zoratto, F., Bianchi, L., Papa, A., Basso, E., Verrico, M., Lo Russo, G., Evangelista, S., Rinaldi, G., Perrone-Congedi, F., Spinelli, G. P., Stati, V., Caruso, D., Prete, A., & Tomao, S. (2013). Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC). Cancer management and research, 5377-85. https://doi.org/10.2147/CMAR.S47986
Rossi, Luigi, et al. "Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)." Cancer management and research vol. 5 (2013): 377-85. doi: https://doi.org/10.2147/CMAR.S47986
Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S. Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC). Cancer Manag Res. 2013 Nov 19;5:377-85. doi: 10.2147/CMAR.S47986. PMID: 24399885; PMCID: PMC3875371.
Copy Download .nbib Format: NLM
Ventricular septal defect: the three-dimensional point of view.

Translational medicine @ UniSa

Parisi V, Ratto E, Silvestri C, Pastore F.
PMID: 24251244
Transl Med UniSa. 2013 May 06;6:41-2. eCollection 2013.

This case highlights the clinical usefulness of three-dimensional (3D) echocardiography. The diagnosis of inter-ventricular septal defect associated with aortic regurgitation has been performed in a 50-year-old man using 3D echocardiography. This advanced echocardiography could accurately reproduce the anatomy of...

Cite
Parisi V, Ratto E, Silvestri C, et al. Ventricular septal defect: the three-dimensional point of view. Transl Med UniSa. 2013;6:41-2
Parisi, V., Ratto, E., Silvestri, C., & Pastore, F. (2013). Ventricular septal defect: the three-dimensional point of view. Translational medicine @ UniSa, 641-2.
Parisi, V, et al. "Ventricular septal defect: the three-dimensional point of view." Translational medicine @ UniSa vol. 6 (2013): 41-2.
Parisi V, Ratto E, Silvestri C, Pastore F. Ventricular septal defect: the three-dimensional point of view. Transl Med UniSa. 2013 May 06;6:41-2. eCollection 2013. PMID: 24251244; PMCID: PMC3829796.
Copy Download .nbib Format: NLM
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer.

OncoTargets and therapy

Zoratto F, Rossi L, Zullo A, Papa A, Zaccarelli E, Tomao L, Giordani E, Colonna M, Baiano G, Tomao S.
PMID: 23055745
Onco Targets Ther. 2012;5:199-211. doi: 10.2147/OTT.S30581. Epub 2012 Sep 24.

Colorectal cancer is one of the most common cancers worldwide. The prognosis of patients with metastatic colorectal cancer in recent years has increased from 5 months with best supportive care to nearly 2 years with chemotherapy combined with bevacizumab,...

Cite
Zoratto F, Rossi L, Zullo A, et al. Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer. Onco Targets Ther. 2012;5:199-211doi: 10.2147/OTT.S30581.
Zoratto, F., Rossi, L., Zullo, A., Papa, A., Zaccarelli, E., Tomao, L., Giordani, E., Colonna, M., Baiano, G., & Tomao, S. (2012). Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer. OncoTargets and therapy, 5199-211. https://doi.org/10.2147/OTT.S30581
Zoratto, Federica, et al. "Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer." OncoTargets and therapy vol. 5 (2012): 199-211. doi: https://doi.org/10.2147/OTT.S30581
Zoratto F, Rossi L, Zullo A, Papa A, Zaccarelli E, Tomao L, Giordani E, Colonna M, Baiano G, Tomao S. Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer. Onco Targets Ther. 2012;5:199-211. doi: 10.2147/OTT.S30581. Epub 2012 Sep 24. PMID: 23055745; PMCID: PMC3460673.
Copy Download .nbib Format: NLM
LETM1-Mediated K.

Frontiers in physiology

Austin S, Tavakoli M, Pfeiffer C, Seifert J, Mattarei A, De Stefani D, Zoratti M, Nowikovsky K.
PMID: 29204122
Front Physiol. 2017 Nov 17;8:839. doi: 10.3389/fphys.2017.00839. eCollection 2017.

Ca

Cite
Austin S, Tavakoli M, Pfeiffer C, et al. LETM1-Mediated K. Front Physiol. 2017;8:839doi: 10.3389/fphys.2017.00839.
Austin, S., Tavakoli, M., Pfeiffer, C., Seifert, J., Mattarei, A., De Stefani, D., Zoratti, M., & Nowikovsky, K. (2017). LETM1-Mediated K. Frontiers in physiology, 8839. https://doi.org/10.3389/fphys.2017.00839
Austin, Shane, et al. "LETM1-Mediated K." Frontiers in physiology vol. 8 (2017): 839. doi: https://doi.org/10.3389/fphys.2017.00839
Austin S, Tavakoli M, Pfeiffer C, Seifert J, Mattarei A, De Stefani D, Zoratti M, Nowikovsky K. LETM1-Mediated K. Front Physiol. 2017 Nov 17;8:839. doi: 10.3389/fphys.2017.00839. eCollection 2017. PMID: 29204122; PMCID: PMC5698270.
Copy Download .nbib Format: NLM
Simple congenital heart disease: a complex challenge for public health.

Journal of thoracic disease

Buratto E, Ye XT, Konstantinov IE.
PMID: 28066566
J Thorac Dis. 2016 Nov;8(11):2994-2996. doi: 10.21037/jtd.2016.11.45.

No abstract available.

Cite
Buratto E, Ye XT, Konstantinov IE. Simple congenital heart disease: a complex challenge for public health. J Thorac Dis. 2016;8(11):2994-2996doi: 10.21037/jtd.2016.11.45.
Buratto, E., Ye, X. T., & Konstantinov, I. E. (2016). Simple congenital heart disease: a complex challenge for public health. Journal of thoracic disease, 8(11), 2994-2996. https://doi.org/10.21037/jtd.2016.11.45
Buratto, Edward, et al. "Simple congenital heart disease: a complex challenge for public health." Journal of thoracic disease vol. 8,11 (2016): 2994-2996. doi: https://doi.org/10.21037/jtd.2016.11.45
Buratto E, Ye XT, Konstantinov IE. Simple congenital heart disease: a complex challenge for public health. J Thorac Dis. 2016 Nov;8(11):2994-2996. doi: 10.21037/jtd.2016.11.45. PMID: 28066566; PMCID: PMC5179375.
Copy Download .nbib Format: NLM
Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in .

Frontiers in physiology

Vitiello L, Marabita M, Sorato E, Nogara L, Forestan G, Mouly V, Salviati L, Acosta M, Blaauw B, Canton M.
PMID: 30154729
Front Physiol. 2018 Aug 14;9:1087. doi: 10.3389/fphys.2018.01087. eCollection 2018.

Oxidative stress and mitochondrial dysfunction play a crucial role in the pathophysiology of muscular dystrophies. We previously reported that the mitochondrial enzyme monoamine oxidase (MAO) is a relevant source of reactive oxygen species (ROS) not only in murine models...

Cite
Vitiello L, Marabita M, Sorato E, et al. Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in . Front Physiol. 2018;9:1087doi: 10.3389/fphys.2018.01087.
Vitiello, L., Marabita, M., Sorato, E., Nogara, L., Forestan, G., Mouly, V., Salviati, L., Acosta, M., Blaauw, B., & Canton, M. (2018). Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in . Frontiers in physiology, 91087. https://doi.org/10.3389/fphys.2018.01087
Vitiello, Libero, et al. "Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in ." Frontiers in physiology vol. 9 (2018): 1087. doi: https://doi.org/10.3389/fphys.2018.01087
Vitiello L, Marabita M, Sorato E, Nogara L, Forestan G, Mouly V, Salviati L, Acosta M, Blaauw B, Canton M. Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in . Front Physiol. 2018 Aug 14;9:1087. doi: 10.3389/fphys.2018.01087. eCollection 2018. PMID: 30154729; PMCID: PMC6102489.
Copy Download .nbib Format: NLM
Recruitment experience for a pragmatic randomized controlled trial: Using EMR initiatives and minimizing research infrastructure.

Clinical research and regulatory affairs

Joseph CL, Ownby DR, Zoratti E, Johnson D, Considine S, Bourgeois R, Melkonian C, Miree C, Johnson CC, Lu M.
PMID: 28479846
Clin Res Regul Aff. 2016;33(2):25-32. doi: 10.1080/10601333.2016.1182693. Epub 2016 Jun 01.

CONTEXT: Modernized approaches to multisite randomized controlled trials (RCT) include the use of electronic medical records (EMR) for recruitment, remote data capture (RDC) for multisite data collection, and strategies to reduce the need for research infrastructure. These features facilitate...

Cite
Joseph CL, Ownby DR, Zoratti E, et al. Recruitment experience for a pragmatic randomized controlled trial: Using EMR initiatives and minimizing research infrastructure. Clin Res Regul Aff. 2016;33(2):25-32doi: 10.1080/10601333.2016.1182693.
Joseph, C. L., Ownby, D. R., Zoratti, E., Johnson, D., Considine, S., Bourgeois, R., Melkonian, C., Miree, C., Johnson, C. C., & Lu, M. (2016). Recruitment experience for a pragmatic randomized controlled trial: Using EMR initiatives and minimizing research infrastructure. Clinical research and regulatory affairs, 33(2), 25-32. https://doi.org/10.1080/10601333.2016.1182693
Joseph, Christine Lm, et al. "Recruitment experience for a pragmatic randomized controlled trial: Using EMR initiatives and minimizing research infrastructure." Clinical research and regulatory affairs vol. 33,2 (2016): 25-32. doi: https://doi.org/10.1080/10601333.2016.1182693
Joseph CL, Ownby DR, Zoratti E, Johnson D, Considine S, Bourgeois R, Melkonian C, Miree C, Johnson CC, Lu M. Recruitment experience for a pragmatic randomized controlled trial: Using EMR initiatives and minimizing research infrastructure. Clin Res Regul Aff. 2016;33(2):25-32. doi: 10.1080/10601333.2016.1182693. Epub 2016 Jun 01. PMID: 28479846; PMCID: PMC5417689.
Copy Download .nbib Format: NLM
Mild Cognitive Impairment Subtypes and Type 2 Diabetes in Elderly Subjects.

Journal of clinical medicine

Valenza S, Paciaroni L, Paolini S, Bonfigli AR, Di Rosa M, Rabini RA, Tortato E, Pelliccioni P, Pelliccioni G.
PMID: 32629878
J Clin Med. 2020 Jun 30;9(7). doi: 10.3390/jcm9072055.

BACKGROUND: Type 2 diabetes (T2D) is correlated to amnestic mild cognitive impairment (aMCI) and to non-amnestic mild cognitive impairment (naMCI). This study evaluated whether the T2D variable characterizes a peculiar cognitive profile in elderly patients. Moreover, it explores the...

Cite
Valenza S, Paciaroni L, Paolini S, et al. Mild Cognitive Impairment Subtypes and Type 2 Diabetes in Elderly Subjects. J Clin Med. 2020;9(7)doi: 10.3390/jcm9072055.
Valenza, S., Paciaroni, L., Paolini, S., Bonfigli, A. R., Di Rosa, M., Rabini, R. A., Tortato, E., Pelliccioni, P., & Pelliccioni, G. (2020). Mild Cognitive Impairment Subtypes and Type 2 Diabetes in Elderly Subjects. Journal of clinical medicine, 9(7), . https://doi.org/10.3390/jcm9072055
Valenza, Silvia, et al. "Mild Cognitive Impairment Subtypes and Type 2 Diabetes in Elderly Subjects." Journal of clinical medicine vol. 9,7 (2020). doi: https://doi.org/10.3390/jcm9072055
Valenza S, Paciaroni L, Paolini S, Bonfigli AR, Di Rosa M, Rabini RA, Tortato E, Pelliccioni P, Pelliccioni G. Mild Cognitive Impairment Subtypes and Type 2 Diabetes in Elderly Subjects. J Clin Med. 2020 Jun 30;9(7). doi: 10.3390/jcm9072055. PMID: 32629878; PMCID: PMC7408775.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 176 entries